Vaccine World Asia Congress 2025—South East Asia

Policy & regional collaboration

The congress will address multiple topics including examining how political and economic instability may affect immunization programs across Southeast Asia. Nakorn Premsri (National Vaccine Institute, Thailand) will lead a session on ASEAN Vaccine Security and Self-Reliance, focusing on regional manufacturing, supply chain resilience, and sustainable vaccine access.

A leadership panel chaired by Nizam Uddin Ahmed (Synesis Health) will explore cross-border collaboration, equitable access, and budgetary strategies for vaccine rollout. Panelists will include Dr Mohd Azlan bin Zaharudin (Ministry of Science, Technology & Innovation, Malaysia) Luigi Bonfatti (RVMC, Norway) and Fitriana Rahmawati (PT Biofarma, Indonesia).

Discovery & preclinical development

The agenda will feature cutting-edge research in malaria, leptospirosis, and Nipah virus vaccines. Takafumi Tsuboi (Ehime University) will present on wheat germ cell-free systems for malaria vaccine candidate discovery. Kanitha Patarakul (Chula Vaccine Research Center) and Jetsumon Sattabongkot (Mahidol Vivax Research Unit) will discuss mRNA platforms for leptospirosis and Plasmodium vivax, respectively. Pei Yin Lim (Hilleman Laboratories) will share preclinical data on a circular RNA vaccine candidate for Nipah virus.

Clinical trials & real-world data

A panel on clinical trial infrastructure in Southeast Asia will address adaptive designs, population diversity, and regulatory harmonization. Edwin Simjaya (PT Kalbe Farma) will highlight cybersecurity risks in digital trials, while sessions on adaptive and decentralized trial models will explore innovations in trial speed, retention, and data quality.

Manufacturing & formulation

Vipul Doshi (Zydus Lifesciences) will lead a session on scaling vaccine production from lab to commercial scale, with emphasis on quality control and tech transfer. A panel featuring Prashant Chawla (Biological E Limited) will discuss formulation innovations, including adjuvant technologies and stability optimization.

Next-generation vaccine platforms & delivery mechanisms

This program will include a special session by Amaran Biotech covering the topic Building the Future on a Solid Foundation: How Superior Adjuvants AB-801 Accelerate Vaccine Commercialization. Other speakers include Petro Terblanche (Afrigen Biologics) on mRNA vaccine development in LMICs, Waranyoo Phoolcharoen (Baiya Phytopharm) on plant-based biomanufacturing, and Seyed Reza Banihashemi (Razi Institute) on respiratory vaccine delivery systems, including aerosol and nanoparticle technologies.

Ensuring access

Sessions will explore adult immunization, vaccine hesitancy, and coverage in underserved populations. Nirutti Pradubyati (Pfizer) will present on preventive vaccines for non-infectious diseases, including cancer and diabetes. A panel on vaccine safety funding will address public trust and political influences, while Badarulhisam Abdul Rahman (Pharmaniaga) will discuss Halal vaccine development.

Distribution sessions will cover cold chain risks, last-mile delivery, and supply chain resilience, with insights from Sebastian Chua (Supply Chain Asia).

The congress will conclude with a panel on equitable vaccine distribution during outbreaks, reflecting on lessons from COVID-19 and future strategies for global health preparedness.

Readers of Vaccine Insights can claim a 15% discount on delegate tickets—just reach out to rima.karan@imapac.com! You can find out more about the event here.

To learn about other events coming up in your field, you can find our online Events Calendars here.